This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing.

The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.